COVID-19 Clinical Trials in Los Angeles

Showing 41-60 of 118 trials

Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up

NCT05586204

This is a prospective randomized clinical trial evaluating how behaviorally-informed outreach text messages affect the take-up of bivalent COVID-19 booster. The investigators will test the impact of sending text reminders as well as the importance of elevating vaccination intentions, facilitating action, and their combination.

COVID-19Vaccines

University of California, Los Angeles154,977 participantsStarted Oct 2022

Los Angeles, California, United States

COMPLETEDNA< 1 mile

Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake

NCT05586178

This study investigates different ways to elevate intentions to get the COVID-19 booster via text-based reminders, including providing information about the booster and leveraging the consistency principle. The proposed randomized controlled trial will examine the impact of these reminders on booster uptake.

COVID-19Vaccines

University of California, Los Angeles177,720 participantsStarted Oct 2022

Los Angeles, California, United States

Boost Intentions and Facilitate Action to Promote COVID-19 Booster Take-up

Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake

COVID-19 Trials in Other Cities

Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities

Predictors of Severe COVID-19 Outcomes

COVID-19 Risk Reduction Among African American Parishioners

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL

Developing and Testing a COVID-19 Vaccination Acceptance Intervention

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Other Conditions in Los Angeles